07:00 , May 27, 2013 |  BC Week In Review  |  Financial News

Bioarray Therapeutics completes venture financing

Bioarray Therapeutics Inc. , Farmington, Conn.   Business: Diagnostic   Date completed: 5/20/13   Type: Venture financing   Raised: $150,000   Investor: Connecticut Innovations  ...
07:00 , Aug 14, 2006 |  BioCentury  |  Tools & Techniques

Microfluidics in 3-D

Researchers published in the Proceedings of the National Academy of Sciences the development of a technique to produce microfluidic devices composed of polydimethylsiloxane (PDMS) with three-dimensional connectivity that could lead to faster and cheaper bioarray...
07:00 , Oct 10, 2005 |  BC Week In Review  |  Company News

Ambion, General Electric deal

GE's GE Healthcare unit will use its CodeLink Bioarray technology to manufacture microRNA (miRNA) microarrays for Ambion. Ambion Inc. , Austin, Texas   General Electric Co. (GE), Fairfield, Conn.   Business: Microarrays  ...
07:00 , Aug 16, 2004 |  BC Week In Review  |  Company News

General Electric sales and marketing update

GE Healthcare (London, U.K.), a unit of GE, launched a Rat Whole Genome Bioarray. The array is part of GE Healthcare's CodeLink microarray portfolio. General Electric Co. (GE), Fairfield, Conn.   Business: Microarrays  ...
07:00 , May 17, 2004 |  BioCentury  |  Finance

Ebb & Flow

With 21 U.S. IPOs already floated in the States since last October, European investors have been waiting for the European biotech window to crack open. One could argue talk is still cheap, but many now...
07:00 , Apr 12, 2004 |  BC Week In Review  |  Company News

Amersham sales and marketing update

AHM launched its CodeLink Human Whole Genome Bioarray for genome-wide expression profiling. Amersham plc (LSE:AHM; AHM), London, U.K.   Business: Microarrays  ...
07:00 , Sep 15, 2003 |  BC Week In Review  |  Company News

Amersham sales and marketing update

AHM's Amersham Biosciences launched CodeLink Human P450 SNP Bioarray, an addition to its existing CodeLink expression and SNP bioarray range. The bioarray is designed for screening clinical trial populations to determine their toxicogenetic profiles, and...
07:00 , Jul 29, 2002 |  BC Week In Review  |  Company News

Amersham, Motorola Inc. deal

AHM paid $20 million for CodeLink (Tempe, Ariz.), the bioarray unit of MOT's life science business. AHM expects to continue manufacturing at the Tempe plant and to transfer key MOT personnel to AHM. Amersham plc...
07:00 , Jul 29, 2002 |  BioCentury  |  Strategy

Ebsworth's quick decision on Zavesca

Rather than develop a post-marketing pharmacovigilance system for its Zavesca Gaucher disease treatment and build a sales and marketing force from the ground up, Oxford Glycosciences plc has opted to put these launch responsibilities in...
07:00 , Jul 25, 2002 |  BC Extra  |  Company News

Motorola exiting research bioarrays

MOT said it is exiting the research microarray market and is selling the CodeLink (Tempe, Ariz.) bioarray unit of its life sciences business to Amersham (AHM; LSE:AHM) for $20 million. AHM expects to continue manufacturing...